Cargando…

Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals

OBJECTIVES: Among antiretroviral therapy (ART)-naive individuals, viral load levels tend to increase and CD4(+) cell counts decline over time. We sought to explore the rate of change and influence of other factors associated with these markers of HIV progression. DESIGN: An observational cohort coll...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Epidemiology and Social: CONCISE COMMUNICATIONS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032217/ https://www.ncbi.nlm.nih.gov/pubmed/24959963 http://dx.doi.org/10.1097/QAD.0000000000000224

Ejemplares similares

Impact on life expectancy of HIV-1 positive individuals of CD4(+) cell count and viral load response to antiretroviral therapy
por: May, Margaret T., et al.
Publicado: (2014)

HIV and urethritis: time required for antiretroviral therapy to suppress HIV in semen
por: Matoga, Mitch, et al.
Publicado: (2023)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
por: Kasirye, Ronnie P., et al.
Publicado: (2017)

Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda
por: Haberer, Jessica E., et al.
Publicado: (2016)

Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
por: Winand, Raf, et al.
Publicado: (2015)

Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients
por: Godin, Arnaud, et al.
Publicado: (2021)

Benefits and harms of lung cancer screening in HIV-infected individuals with CD4(+) cell count at least 500 cells/μl
por: Kong, Chung Yin, et al.
Publicado: (2018)

Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
por: Vourli, Georgia, et al.
Publicado: (2019)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
por: Helleberg, Marie, et al.
Publicado: (2015)

How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data
por: Mammone, Alessia, et al.
Publicado: (2016)

Acute HIV-1 infection is as common as malaria in young febrile adults seeking care in coastal Kenya
por: Sanders, Eduard J., et al.
Publicado: (2014)

Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects
por: Vasylyeva, Tetyana I., et al.
Publicado: (2016)

Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection
por: Aldersley, Jordan, et al.
Publicado: (2019)

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia
por: Gilbert, Mark, et al.
Publicado: (2013)

Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4(+) cell counts: findings from a cluster-randomized trial
por: Woodd, Susannah L., et al.
Publicado: (2014)

Associations of gender and serum total cholesterol with CD4+ T cell count and HIV RNA load in antiretroviral-naïve individuals in Addis Ababa
por: Adal, Melaku, et al.
Publicado: (2018)

A short‐term in vivo model for Merkel Cell Carcinoma
por: Bhat, Vishwanath Kumble, et al.
Publicado: (2018)

Does antiretroviral therapy change partnership dynamics and HIV risk behaviours among HIV-infected adults
por: McGrath, Nuala, et al.
Publicado: (2017)

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4(+) T-cell recovery once HIV-1 suppression is achieved?
por: Jarrin, Inma, et al.
Publicado: (2015)

Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
por: Cale, Evan M., et al.
Publicado: (2020)

Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic
por: Mzembe, Themba, et al.
Publicado: (2018)

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
por: Shroufi, Amir, et al.
Publicado: (2019)

HIV-associated wasting prevalence in the era of modern antiretroviral therapy
por: Siddiqui, Javeed, et al.
Publicado: (2022)

Preexisting memory CD4(+) T cells contribute to the primary response in an HIV-1 vaccine trial
por: Campion, Suzanne L., et al.
Publicado: (2021)

Dosing antiretroviral medication when crossing time zones: a review
por: Lewis, Joseph M., et al.
Publicado: (2016)

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis
Publicado: (2016)

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
por: Kaulich-Bartz, Josee, et al.
Publicado: (2013)

Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
por: Phillips, Andrew N., et al.
Publicado: (2015)

Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis
por: Kim, Sung-Hee, et al.
Publicado: (2014)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy
por: Szubert, Alexander J., et al.
Publicado: (2015)

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1
Publicado: (2019)

Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa
por: Lippman, Sheri A., et al.
Publicado: (2023)

Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom
por: van Halsema, Clare L., et al.
Publicado: (2020)

Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda
por: Siedner, Mark J., et al.
Publicado: (2019)

Is the number of prescriptions an appropriate metric for outpatient antimicrobial consumption? A comparison between the prescription counts and days supplied
por: Kakiuchi, Satoshi, et al.
Publicado: (2023)

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States
por: Ross, Lisa L., et al.
Publicado: (2018)

TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF(V600E) melanoma cells
por: Hartman, Mariusz L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_otsc104orhd8prael0vjhajsr2